SCHEMBL4660210

SCHEMBL4660210

OCCCC([SiH3])(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.38
KCNH3 Q9ULD8 2/20 0.35
TDP1 Q9NUW8 1/20 0.34
CYP2C19 P33261 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CHRM4 P08173 5/20 0.34
CHRM5 P08912 5/20 0.34
CHRM3 P20309 5/20 0.34
CHRM2 P08172 4/20 0.34
CHRM1 P11229 4/20 0.34
OPRM1 P35372 3/20 0.34
OPRL1 P41146 1/20 0.34
SIGMAR1 Q99720 2/20 0.33
DRD3 P35462 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DRD4 P21917 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HTR1A P08908 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7427624 0.86 TDP1 (0.37) KIF11TDP1CYP2C19CYP1A2CYP2C9
SCHEMBL19064319 0.78 KIF11 (0.38) KIF11CYP2C19CYP1A2CYP2C9CHRM4
SCHEMBL4194598 0.78 KIF11 (0.38) KIF11CHRM4CHRM5CHRM3CHRM2
SCHEMBL6551716 0.77 KIF11 (0.61) KIF11CYP2C19CYP2C9CHRM4CHRM5
Ammonia Solution, Strong SCHEMBL2922340 0.76 KIF11 (0.59) KIF11CYP2C19CYP2C9CHRM4CHRM5
SCHEMBL7453762 0.76 KIF11 (0.59) KIF11CYP2C19CYP2C9CHRM4CHRM5
SCHEMBL2006125 0.76 CHRM4 (0.56) KIF11CHRM4CHRM5CHRM3CHRM2
SCHEMBL29214644 0.75 SIGMAR1 (0.40) SIGMAR1HTR2AKCNH2
SCHEMBL9172236 0.74 KIF11 (0.57) KIF11CYP2C19CYP2C9CHRM4CHRM5
SCHEMBL8310962 0.74 CHRM3 (0.39) KIF11TDP1CYP2C19CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444239-B1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILYL MONOMERS BAUSCH & LOMB (US) 2008-12-24 EP disclosed
US-7132494-B2 High refractive index aromatic-based silyl monomers BAUSCH & LOMB INCORPORATED (US) 2006-11-07 US disclosed
US-6881809-B2 High refractive index aromatic-based silyl monomers BAUSCH & LOMB INCORPORATED (US) 2005-04-19 US disclosed
US-6846897-B2 High refractive index aromatic-based silyl monomers BAUSCH AND LOMB, INC. (US) 2005-01-25 US disclosed
US-20040230023-A1 High refractive index aromatic-based silyl monomers SALAMONE JOSEPH C (US) 2004-11-18 US disclosed
US-20040215156-A1 High refractive index aromatic-based silyl monomers SOLTA MEDICAL, INC. 2004-10-28 US disclosed
US-20040215032-A1 High refractive index aromatic-based silyl monomers SALAMONE JOSEPH C 2004-10-28 US disclosed
US-20040210023-A1 High refractive index aromatic-based silyl monomers SALAMONE JOSEPH C (US) 2004-10-21 US disclosed
EP-1444239-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILYL MONOMERS BAUSCH & LOMB INCORPORATED (US) 2004-08-11 EP disclosed
US-6762271-B2 INTRAOCULAR LENSES, CONTACT LENSES AND CORNEAL INLAYS BAUSCH & LOMB INCORPORATED 2004-07-13 US disclosed
US-20030105255-A1 High refractive index aromatic-based silyl monomers BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC. (CA) 2003-06-05 US disclosed
WO-2003040152-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILYL MONOMERS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040215032-A1 High refractive index aromatic-based silyl monomers SMAD2, SMAD3, FHIT KIF11 1305/4885KCNH3 1604/4885TDP1 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.